Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ethinylestradiol/levonorgestrel transdermal - Agile Therapeutics

X
Drug Profile

Ethinylestradiol/levonorgestrel transdermal - Agile Therapeutics

Alternative Names: AG 200 ER; AG 200 ER (SmP); AG 200 SP; AG-200-15; AG200 15 (SmP); Ethinyl estradiol and levonorgestrel transdermal system; Low dose EE/LNG; Twirla

Latest Information Update: 29 Aug 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Agile Therapeutics
  • Class Alkylated estrogenic steroids; Contraceptives; Hormonal replacements; Norpregnanes; Norpregnatrienes; Small molecules
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Pregnancy

Most Recent Events

  • 26 Aug 2024 Agile Therapeutics has been acquired by Insud Pharma
  • 01 Aug 2022 Agile Therapeutics and Nurx agrees for supply of Ethinylestradiol/levonorgestrel
  • 10 Jan 2022 Agile Therapeutics and Afaxys Pharma enters into partnership agreement for the promotion of ethinylestradiol and levonorgestrel transdermal system in the USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top